Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Guerbet
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Referred for contrast-enhanced MRI using gadoversetamide;
Have a documented estimated glomerular filtration rate (eGFR) of \<60 mL/min/1.73 m2 within the past 6 months or ESRD requiring dialysis; and
Willing and able to provide written consent (themselves or by a legally authorized representative) and agree to abide by study requirements, including being seen by a dermatologist and undergoing a skin biopsy if NSF is suspected.
You may not be if
Have experienced a previous hypersensitivity reaction to a GBCA;
Have pre-existing NSF or NSF-like symptoms; or
Have been exposed to a GBCA within 12 months prior to the index procedure; or
Has a medical condition or other personal situation that would prevent providing follow-up information, completing clinic visits or otherwise supplying meaningful data to meet study objectives.
Clareo Health | Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection
